 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
MiNK Therepeutics
INKT
conference date: March 31, 2026 @ 5:30 AM Pacific Time
MiNK Therapeutics: iNKT Therapy Data Should Drive Stock Price Up [March 25, 2023 at Seeking Alpha]
MiNK Therapeutics Undervalued Given Platform Potential [December 5, 2022 at Seeking Alpha]
MiNK Therapeutics a Bargain for Cell Therapies [June 23, 2022 at Seeking Alpha]
| 2025 | |||
| Mink Therapeutics Q1 2025 |
Mink Therapeutics Q2 2025 |
Mink Therapeutics Q3 2025 |
Mink Therapeutics Q4 2025 |
| May 15, 2025 | Aug. 14, 2025 | Nov. 14, 2025 | Mar. 31, 2026 |
| 2024 | |||
| Mink Therapeutics Q1 2024 |
Mink Therapeutics Q2 2024 |
Mink Therapeutics Q3 2024 |
Mink Therapeutics Q4 2024 |
| May 14, 2024 | Aug. 13, 2024 | Nov. 14, 2024 | March 18, 2025 |
| 2023 | |||
| Mink Therapeutics Q1 2023 |
Mink Therapeutics Q2 2023 |
Mink Therapeutics Q3 2023 |
Mink Therapeutics Q4 2023 |
| May 11, 2023 | Aug. 10, 2023 | Nov. 9, 2023 | Mar. 21, 2024 |
| 2022 | |||
| Mink Therapeutics Q1 2022 Press Release |
Mink Therapeutics Q2 2022 |
Mink Therapeutics Q3 2022 |
Mink Therapeutics Q4 2022 |
| May 10, 2022 | Aug. 9, 2022 | Nov. 3, 2022 | March 21, 2023 |
MiNK Therapeutics (INKT) is a clinical-stage biotechnology company specializing in cell therapies for cancers and immunological diseases.
Note: Agenus (AGEN) owns a minority of the shares of INKT common stock, c. late 2025.
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALLO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| BOLD |
| CCCC |
| CLDX |
| CBIO |
| FATE |
| GILD |
| ILMN |
| INCY |
| INKT |
| INO |
| IONS |
| IOVA |
| LGND |
| MCHP |
| MRNA |
| PASG |
| REGN |
| RXRX |
| SANA |
| SUPN |
| VRTX |
| VSTM |
| XNCR |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2026 William P. Meyers